trial

Psychological Intervention for Relapse Prevention in First Episode Schizophrenia

NCTId NCT00161408
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 106
Sponsored by University Hospital Tuebingen
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
106
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2000-12
Primary completion
—
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
cognitive behavioural therapyPsychoeducation

Sponsors

University Hospital TuebingenLead Sponsor

Investigators

1
Stefan Klingberg, PD Dr. phil. Dipl. Psych.Principal Investigator

Sites

5 total
Bonn, GermanyCologne, GermanyDüsseldorf, GermanyMünchen, GermanyTübingen, Germany

Facts & assertions

3 sourced
Enrollment
106
Phase
NA
Status
UNKNOWN
relationships
The graph out of here
drug
cognitive behavioural therapy
drug
Psychoeducation
drug
lead_sponsor
University Hospital Tuebingen
company
indication
Schizophrenic Disorders
indication
Schizophrenia
indication
investigator
Stefan Klingberg, PD Dr. phil. Dipl. Psych.
person